Cargando…
Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B
Hemophilia B is an X-linked genetic disease caused by mutation of the gene for coagulation protein factor IX (FIX), with an incidence of approximately once every 30,000 male births in all populations and ethnic groups. When severe, the disease leads to spontaneous life threatening bleeding episodes....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133029/ https://www.ncbi.nlm.nih.gov/pubmed/25143713 http://dx.doi.org/10.2147/PPA.S54951 |